This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Somerville, NJ (US) (1981)
- Flemington, NJ (US) (1981)
Company Filing History:
Years Active: 1981
Title: The Innovations of Harry M Geyer
Introduction
Harry M Geyer is a notable inventor based in Somerville, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of isoquinoline derivatives. With a total of 2 patents, Geyer has focused on creating compounds that have potential therapeutic applications.
Latest Patents
Geyer's latest patents include innovative compounds such as 3-Piperidino or piperazino-1-phenyl isoquinolines. These compounds are characterized by specific structural formulas where R1 can be piperidino or piperazino, and R2 is phenyl or its substituted variants. His work emphasizes the preparation of these isoquinolines and their use as antidepressants, showcasing their potential in the pharmaceutical industry.
Career Highlights
Harry M Geyer is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His research and inventions have contributed to advancements in medicinal chemistry, particularly in developing new antidepressant medications. Geyer's work is recognized for its potential impact on mental health treatment.
Collaborations
Geyer has collaborated with notable coworkers such as Wilhelm Bartmann and Elmar Konz. These partnerships have likely enhanced the research and development of his innovative compounds, fostering a collaborative environment for scientific advancement.
Conclusion
Harry M Geyer stands out as an influential inventor in the field of medicinal chemistry. His contributions, particularly in the development of isoquinoline derivatives, highlight his commitment to advancing therapeutic options for mental health. His work continues to inspire innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
